上和集團在放射醫學事業部實踐創新策略，主要為“蟹足腫”與“表淺性皮膚癌”提供數位醫學影像合併放射線治療。
上和集團於2022年3月取得最新衛福部核准之表淺性放射線治療，並取得美國Sensus SRT 之獨家代理權引進最新的數位醫學影像合併放射線治療，該平台可存取數位資料，為放射科醫師及皮膚科、整形外科等團隊提供疾病相關的解決方案。
Upbeat Group implements innovative strategies in the Radiation Medicine Division, mainly providing digital medical imaging combined with radiation therapy for “keloids” and “superficial skin cancer.”
Upbeat Group obtained the brand new superficial radiation therapy, approved by the Ministry of Health and Welfare in March 2022; Concurrently, the Group also became the sole agency of Sensus SRT from the United States to introduce the latest digital medical image combined radiation therapy. The device allows digital information storage that provides disease-related solutions for radiology, dermatology, plastic surgery, and other teams of physicians.
